36 min listen
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
ratings:
Length:
51 minutes
Released:
May 9, 2022
Format:
Podcast episode
Description
4D pharma's flagship early-stage clinical candidates are live biotherapeutics, a relatively new class of biologics that seek to impact disease state by modulating the microbiome. CEO Duncan Peyton is leading the effort to understand how the health of the microbiome relates to a wide range of diseases, including immuno-oncology, central nervous system disorders, respiratory disease, auto immune indications, and gastro intestinal disease. 4D pharma is even working on a live biotherapeutic vaccine platform. Join Duncan on this episode of the Business of Biotech as we discuss this new frontier of therapeutic exploration.Learn more about gut microbiome therapeutic up-and-comers at bioprocessonline.com.
Released:
May 9, 2022
Format:
Podcast episode
Titles in the series (100)
Summer Sessions 3: Jeff Wolf Builds Heat Bio On Its Therapeutic Platform by Business Of Biotech